샘플 요청 목록

 카트 문의
시장보고서
상품코드
1786465

세계의 약물 용출 풍선 카테터 시장

Drug-Eluting Balloon Catheters
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 279 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

약물 용출 풍선 카테터 세계 시장은 2030년까지 9억 3,590만 달러에 달할 전망

2024년에 6억 1,880만 달러로 추정되는 약물 용출 풍선 카테터 세계 시장은 2024년부터 2030년까지 CAGR 7.1%로 성장하여 2030년에는 9억 3,590만 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석되고 있는 부문 중 하나인 폴리우레탄은 CAGR 6.1%를 기록하며 분석 기간 종료시에는 5억 3,270만 달러에 달할 것으로 예측됩니다. 나일론 부문의 성장률은 분석 기간 동안 CAGR 8.1%로 추정됩니다.

미국 시장은 1억 6,860만 달러로 추정, 중국은 CAGR 11.0%로 성장 예측

미국의 약물 용출 풍선 카테터 시장은 2024년에 1억 6,860만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년 분석 기간 동안 CAGR 11.0%로 성장하여 2030년에는 1억 9,430만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 3.6%와 6.8%로 예측됩니다. 유럽에서는 독일이 CAGR 4.7%로 성장할 것으로 예측됩니다.

세계의 "약물 용출 풍선 카테터" 시장 - 주요 동향과 촉진요인 정리

약물 용출 풍선 카테터가 혈관 중재시술에 선택되는 이유는 무엇인가?

심혈관질환(CVDs) 및 말초동맥질환(PADs)의 증가로 인해 기존 스텐트를 대체할 수 있는 최소침습적이고 효과적인 약물 용출형 풍선(DEB) 카테터에 대한 수요가 크게 증가하고 있습니다. 이 카테터는 파클리탁셀이나 시롤리무스와 같은 항증식제를 환부 동맥에 직접 전달하여 재협착을 감소시키고 재수술의 필요성을 최소화합니다. 영구적인 임플란트를 남기는 약물 용출 스텐트(DES)와 달리 DEB는 일시적이면서도 효과적인 치료 솔루션을 제공하며, 후기 혈전증과 같은 장기적인 합병증 없이 혈관의 개통성을 보장합니다. 따라서 DEB는 출혈 위험이 높은 환자나 미세혈관질환, 또는 반복적인 중재시술을 받은 환자에게 특히 유용합니다. 또한, 특히 고령화 사회에서의 최소침습적 치료에 대한 선호도가 높아지면서 관상동맥, 말초동맥, 동정맥루(AVF) 치료에서 DEB 카테터 채택이 확대되고 있습니다.

약물 용출 풍선 카테터의 효능을 높이는 혁신 기술이란?

고분자를 포함하지 않는 약물 코팅, 약물 보유 시간 연장 전략, 표적 약물전달 메커니즘의 혁신이 DEB 기술의 개선을 촉진하고 있습니다. 차세대 친수성 캐리어, 나노 기반 약물 제제, 생체흡수성 재료는 동맥벽에 대한 약물의 접착력을 크게 향상시켜 지속적인 치료 효과를 보장합니다. 풍선 디자인과 카테터 유연성의 발전은 약물전달의 정확성과 안전성을 향상시키고 시술의 위험을 최소화하며 치료 결과를 최적화하고 있습니다. 또한, 혈관내 초음파(IVUS), 광간섭단층촬영(OCT) 등의 실시간 영상 기술이 DEB 시스템에 통합되어 시각화 및 시술 정확도를 향상시킬 수 있게 되었습니다. FDA와 유럽의약품청(EMA) 등 규제기관이 더 많은 적응증에 특화된 DEB를 승인함에 따라 당뇨병성 혈관 합병증, 무릎 아래 중재술, 투석 접근성 유지에 대한 효능을 평가하는 임상시험이 급증하고 있습니다.

규제 의무와 시장 동향은 어떻게 DEB의 채택을 촉진하고 있는가?

여러 혈관 적응증에서 DEB에 대한 규제 당국의 승인이 증가함에 따라 DEB의 세계 보급이 가속화되고 있습니다. 유럽에서는 DEB가 이미 스텐트 내 재협착의 1차 치료제로 널리 사용되고 있으며, 미국 및 아시아태평양의 규제 당국에서도 관상동맥, 말초혈관, 신경혈관까지 적응증을 확대하고 있습니다. 병원과 외래 수술 센터는 비용 효율성과 입원 기간 단축을 이유로 카테터를 이용한 치료로 전환하고 있으며, 이는 수요를 더욱 촉진하고 있습니다. 또한, 가치 기반 의료와 외래 혈관성형술을 장려하는 정부 이니셔티브가 DEB의 활용을 강력하게 촉진하고 있습니다. DEB와 생체흡수성 스캐폴드를 결합한 하이브리드 시술의 중요성이 강조되고 있는 것도 장기적인 혈관 치료 결과를 개선하는 주요 시장 트렌드입니다.

시장 성장의 주요 촉진요인은?

약물 용출 풍선 카테터 시장의 성장은 심혈관질환 및 말초동맥 질환의 부담 증가, 약물전달 나노기술의 발전, 최소침습적 혈관 내 치료의 채택률 증가에 기인합니다. DEB의 용도가 관상동맥중재술 이외에도 확대되고 있으며, 특히 당뇨병성 족부궤양, 중증 허혈성 사지, 혈액투석 접근성 장애 치료는 새로운 시장 기회를 창출하고 있습니다. 또한, 의료비 지출 증가, 중재적 심장학에 대한 투자 증가, 외래 혈관성형센터로의 전환이 시장 확대를 뒷받침하고 있습니다. 지속적인 기술 발전과 지속적인 임상 검증을 통해 DEB 카테터는 차세대 혈관 치료의 필수적인 요소로 자리 잡고 있습니다.

부문

소재(폴리우레탄, 나일론, 기타), 최종사용(병원 및 클리닉, 외래 수술 센터, 카테터 검사실)

조사 대상 기업 사례

  • Balton Sp z o.o.
  • Becton, Dickinson and Company
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Concept Medical Inc.
  • Eurocor GmbH
  • iVascular S.L.U
  • JIANGSU CHANGMEI MEDTECH CO., LTD

AI 통합

우리는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.14

Global Drug-Eluting Balloon Catheters Market to Reach US$935.9 Million by 2030

The global market for Drug-Eluting Balloon Catheters estimated at US$618.8 Million in the year 2024, is expected to reach US$935.9 Million by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Polyurethane, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$532.7 Million by the end of the analysis period. Growth in the Nylon segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$168.6 Million While China is Forecast to Grow at 11.0% CAGR

The Drug-Eluting Balloon Catheters market in the U.S. is estimated at US$168.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$194.3 Million by the year 2030 trailing a CAGR of 11.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global "Drug-Eluting Balloon Catheters" Market - Key Trends & Drivers Summarized

Why Are Drug-Eluting Balloon Catheters a Preferred Choice for Vascular Interventions?

The rise in cardiovascular diseases (CVDs) and peripheral artery diseases (PADs) has significantly increased the demand for drug-eluting balloon (DEB) catheters, which offer a less invasive and highly effective alternative to traditional stents. These catheters deliver antiproliferative drugs, such as paclitaxel and sirolimus, directly to the affected arteries, reducing restenosis and minimizing the need for repeat procedures. Unlike drug-eluting stents (DES), which leave behind a permanent implant, DEBs provide a transient yet effective therapeutic solution, ensuring vessel patency without long-term complications like late thrombosis. This makes them particularly beneficial for patients with high risks of bleeding, small vessel disease, or those undergoing repeat interventions. Additionally, the growing preference for minimally invasive procedures, especially among aging populations, has driven the increased adoption of DEB catheters in coronary, peripheral, and arteriovenous fistula (AVF) treatments.

What Innovations Are Enhancing the Effectiveness of Drug-Eluting Balloon Catheters?

Breakthroughs in polymer-free drug coatings, prolonged drug retention strategies, and targeted drug delivery mechanisms are driving improvements in DEB technology. Next-generation hydrophilic carriers, nano-based drug formulations, and bioabsorbable materials have significantly enhanced drug adhesion to arterial walls, ensuring sustained therapeutic effects. Advancements in balloon design and catheter flexibility have also improved the precision and safety of drug delivery, minimizing procedural risks and optimizing outcomes. Furthermore, real-time imaging technologies, including intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are now being integrated into DEB systems, allowing for enhanced visualization and placement accuracy. As regulatory bodies such as the FDA and European Medicines Agency (EMA) approve more indication-specific DEBs, the market is witnessing a surge in clinical trials evaluating their efficacy in diabetic vascular complications, below-the-knee interventions, and dialysis access maintenance.

How Are Regulatory Mandates and Market Trends Driving Adoption?

The increasing regulatory approvals for DEBs across multiple vascular indications have accelerated their global adoption. In Europe, drug-eluting balloon catheters have already gained widespread acceptance as a first-line treatment for in-stent restenosis, while regulatory agencies in the U.S. and Asia-Pacific are expanding approvals for coronary, peripheral, and even neurovascular applications. Hospitals and ambulatory surgical centers are shifting towards catheter-based interventions due to their cost-effectiveness and shorter hospital stays, further fueling demand. Additionally, government initiatives promoting value-based healthcare and outpatient angioplasty procedures have provided a strong push toward DEB utilization. The growing emphasis on hybrid procedures that combine DEBs with bioresorbable scaffolds is also a key market trend, offering better long-term vascular healing outcomes.

What Are the Primary Market Growth Drivers?

The growth in the Drug-Eluting Balloon Catheter market is driven by the increasing burden of cardiovascular and peripheral artery diseases, advancements in drug delivery nanotechnology, and the rising adoption of minimally invasive endovascular procedures. The expansion of DEB applications beyond coronary interventions, particularly in treating diabetic foot ulcers, critical limb ischemia, and hemodialysis access failures, has created new market opportunities. Additionally, rising healthcare expenditures, increasing investments in interventional cardiology, and the shift toward outpatient angioplasty centers are supporting market expansion. With ongoing technological advancements and continuous clinical validation, DEB catheters are poised to become an indispensable component of next-generation vascular care.

SCOPE OF STUDY:

The report analyzes the Drug-Eluting Balloon Catheters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Material (Polyurethane, Nylon, Others); End-Use (Hospitals & Clinics, Ambulatory Surgery Centers, Catheterization Laboratories)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Balton Sp z o.o.
  • Becton, Dickinson and Company
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Concept Medical Inc.
  • Eurocor GmbH
  • iVascular S.L.U
  • JIANGSU CHANGMEI MEDTECH CO., LTD

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Drug-Eluting Balloon Catheters - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Peripheral Artery Disease Spurs Demand for Drug-Eluting Balloon Catheters
    • Aging Population and Prevalence of Chronic Cardiovascular Conditions Strengthen Business Case for Drug-Eluting Therapies
    • Increasing Preference for Minimally Invasive Procedures Accelerates Adoption of Drug-Eluting Balloon Catheters
    • Clinical Success and Favorable Outcomes Propel Growth of Drug-Eluting Balloon Technologies
    • Shorter Recovery Times and Reduced Restenosis Risk Drive Demand in Outpatient and Day-Care Surgical Settings
    • Technological Innovations in Drug Coating and Delivery Systems Expand Addressable Market Opportunity
    • Surge in Endovascular Interventions Across Emerging Economies Throws the Spotlight on Drug-Eluting Balloons
    • Shift from Traditional Angioplasty to Drug-Eluting Devices Fuels Market Transformation
    • Integration of Biodegradable Materials in Balloon Catheters Drives Innovation-Led Growth
    • Favorable Reimbursement Policies in Developed Markets Sustain Growth Momentum
    • Expanding Pipeline of Clinical Trials and Regulatory Approvals Unlocks New Market Avenues
    • Expansion of Ambulatory Surgical Centers Across Urban and Semi-Urban Regions Generates New Demand Nodes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Drug-Eluting Balloon Catheters Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Polyurethane by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Nylon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Nylon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Nylon by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Catheterization Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Catheterization Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Catheterization Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • JAPAN
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • CHINA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • EUROPE
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • FRANCE
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • GERMANY
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • INDIA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Drug-Eluting Balloon Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030
  • AFRICA
    • Drug-Eluting Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Drug-Eluting Balloon Catheters by Material - Polyurethane, Nylon and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Drug-Eluting Balloon Catheters by Material - Percentage Breakdown of Value Sales for Polyurethane, Nylon and Others for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Drug-Eluting Balloon Catheters by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Drug-Eluting Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Catheterization Laboratories for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제